May 21, 2013

final decision - News


Roche Net Income Passes 8% and 58% Profit Increases

Switzerland Roche

Despite a more challenging market, Roche Holdings’ confirmed its full-year outlook on Thursday and posted an 8% jump in its first-half net income because of more drug and diagnostics sales. The Swiss pharmaceutical company also noted that the U.S. Food and Drug Administration has voted to halt the use of Roche’s Avastin drug for treating [...]